Target intelligence / Profile preview

Redox and antioxidant pathways

Molecular classification
Enzyme, Transcription factor, Small molecule, Cofactor
01

Overview

Redox and antioxidant pathways represent a sophisticated network of molecular mechanisms designed to maintain cellular reduction-oxidation (redox) balance. These pathways manage the production and elimination of reactive oxygen species (ROS) and reactive nitrogen species (RNS), which are essential for normal signaling but toxic at high concentrations (PubMed: 25911332). Central to this system is the Nrf2-Keap1 signaling axis, which coordinates the expression of numerous antioxidant and detoxification genes in response to oxidative stress (PubMed: 24791965). Key enzymatic components include superoxide dismutase (SOD), catalase, and the glutathione peroxidase system, while non-enzymatic antioxidants like glutathione and vitamins C and E provide direct scavenging capabilities (StatPearls: NBK537161). Chronic imbalance, or oxidative stress, is implicated in the pathogenesis of neurodegenerative diseases, cardiovascular disorders, and cancer (PubMed: 23626518). Therapeutic strategies targeting these pathways aim to either bolster endogenous defenses through Nrf2 activators or directly neutralize ROS to prevent cellular damage and inflammation.

Other names
Oxidative stress responseRedox signalingAntioxidant defense systemROS/RNS metabolic pathways
02

Mechanism of action

Modulation of redox-sensitive transcription factors (e.g., Nrf2 activation), direct scavenging of reactive oxygen species (ROS), and replenishment of endogenous antioxidant pools such as glutathione (PubMed: 24791965).

03

Biological functions

Redox homeostasisOxidative stress regulationSignal transductionApoptosisMetabolic regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetes mellitusAging
05

Safety considerations

Reductive stressInterference with physiological ROS signalingPotential promotion of tumor survival and chemoresistanceOff-target effects of systemic antioxidant administration
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione/GSSG ratioSuperoxide dismutase (SOD) activityProtein carbonyls

Beyond the preview

Go deeper on Redox and antioxidant pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox and antioxidant pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call